Researchers have established a startup business that could restore hearing that people have lost to construction, traffic, jet planes and even rock concerts.Frequency Therapeutics, based in Farmington and Woburn, Mass., is developing drugs that would activate certain cells, stimulating the regrowth of hair cells in the inner ear to counter “chronic noise-induced hearing loss.””The evolution of our hearing was not meant to hang out on subway platforms or put on earbuds or go to U2 concerts,” said David Lucchino, chief executive officer of Frequency Therapeutics. “There’s a disconnect between the evolution of hearing and the industrialized world we live in.”The company is part of the University of Connecticut’s business incubation program, which aims to provide support to new business startups, and has received $32 million in financing. It is researching technology to develop a gel that would be injected in the middle ear — between the eardrum and oval window — in a doctor’s office procedure of about 30 minutes.The intent is to recreate sensory hair cells — as many as 15,000 in each ear — that act as antenna in converting sound into signals understood by the brain. Or as Lucchino says, how to “biologically hot-wire the inner ear”… Read full this story
- Create a new drugs law for the modern world
- Drug used for more than a decade to treat cancer could cure Covid-19 – outperforming remdesivir in lab tests
- Drug discovery study identifies promising new compound to open constricted airways
- NHS doctors will give critically-ill Covid patients two arthritis drugs after breakthrough trial reveals the 'life-saving' medications cut the risk of death by up to 24%
- Lymphoma drug outperforms Remdesivir against Covid virus
- Chemotherapy drug outperforms remdesivir against coronavirus in lab experiments: Study
- Chemotherapy drug outperforms remdesivir against COVID in lab experiments: Study
- Now here's the good news: Pioneering drugs that almost double bowel cancer survival time are among the medical breakthroughs overlooked in a year of Covid gloom
- Is Matt Hancock backing off mid-February vaccine target ALREADY? Tory MPs accuse Health Secretary of downplaying chances of success and leaving himself 'plenty of wriggle room' - as one gives verdict 'they've not a hope in hell'
- New jab policy will save MANY lives: Jonathan Van Tam says waiting 12 weeks rather than original three is the best way to save most vulnerable from dying of Covid as first boxes of Oxford vaccine arrive
Farmington Medical Startup Targets Hearing Loss With New Drugs have 385 words, post on www.courant.com at May 7, 2017. This is cached page on Vietnam Dance. If you want remove this page, please contact us.